Cited by 770Hepatitis C virus researchLiver physiology and pathologyLiver Disease Diagnosis and Treatment

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Hepatitis C: the clinical spectrum of disease.

Open access

Hoofnagle, J H·1997·Hepatology

Open this paper in CoChat — free account Open PDF

Abstract

Hepatitis C virus (HCV) accounts for approximately 20% of cases of acute hepatitis, 70% of chronic hepatitis, and 30% of end-stage liver disease in the United States. The acute infection has an incubation period of 7 weeks (range, 4-20 weeks) and is symptomatic and icteric in only one third of patients. Serum aminotransferase levels generally increase greater than 10-fold elevated and as symptoms and signs resolve decrease into the normal range. Antibody to HCV is usually but not always present at the time of onset of symptoms. HCV RNA appears in the serum early during the incubation period, increases in titer and peaks at the time of symptoms, and then disappears in resolving disease. Importantly, 85% of patients with acute HCV infection develop chronic infection. In these patients, HCV RNA remains present and in approximately two thirds of patients, aminotransferases remain elevated in the range of 1.5- to 10-fold the upper limit of normal. The course of chronic hepatitis C is variable. Probably fewer than 20% of patients have symptoms and they are usually intermittent, vague, and nonspecific, largely being malaise and easy fatiguability. A small percentage of patients develop extrahepatic manifestations of hepatitis C, including cryoglobulinemia and glomerulonephritis. It is estimated that 20% to 30% of patients with chronic hepatitis C develop cirrhosis, but the process is generally slow and insidious. Once cirrhosis develops, symptoms are more common and the signs of end-stage liver disease can appear with jaundice, weakness, wasting, and gastrointestinal bleeding. Patients with cirrhosis are also at risk for developing hepatocellular carcinoma. Thus, this important liver disease has protean manifestations but is often insidious and can lead to end-stage liver disease despite the presence of few symptoms and signs of illness.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/hep.510260703

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Classification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M. A., Hoofnagle, J. H., Manns, M. P., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,591
Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis
Alter, H. J., Purcell, R. H., Shih, J. W., Melpolder, J. C., Houghton, M., Choo, Q.-L., & Kuo, G. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212202 · Cited by 1,658
Clinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,191
Long-Term Outcome of Hepatitis C Infection after Liver Transplantation
Gane, E. J., Portmann, B. C., Naoumov, N. V., Smith, H. M., Underhill, J. A., Donaldson, P. T., Maertens, G. G., & Williams, R. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603283341302 · Cited by 963
Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection
Johnson, R. J., Gretch, D. R., Yamabe, H., Hart, J., Bacchi, C. E., Hartwell, P., Couser, W. G., Corey, L., Wener, M. H., Alpers, C. E., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302183280703 · Cited by 870
Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease
Houghton, M., Weiner, A. J., Han, J. H., Kuo, G. C., & Choo, Q. (1991) · Hepatology · doi:10.1002/hep.1840140227 · Cited by 862
Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.
Weiner, A. J., Geysen, H. M., Christopherson, C., Hall, J. E., Mason, T. J., Saracco, G. M., Bonino, F., Crawford, K., Marion, C. D., & Crawford, K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3468 · Cited by 703
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
Seeff, L. B., Buskell‐Bales, Z., Wright, E. C., Durako, S. J., Alter, H. J., Iber, F. L., Hollinger, F. B., Gitnick, G., Knodell, R. G., Perrillo, R. P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272703 · Cited by 668
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Colombo, M., Choo, Q. L., Ninno, E. D., Dioguardi, N., Kuo, G. C., Donato, M. F., Tommasini, M., & Houghton, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91016-7 · Cited by 666
Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus Infection
Conry‐Cantilena, C., VanRaden, M. J., Gibble, J. W., Melpolder, J. C., Shakil, A. O., Viladomiu, L., Cheung, L., DIBISCEGLIE, A., Hoofnagle, J. H., Shih, J. W., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342602 · Cited by 627

Flagged first, then by citations

Show all 47 references

Research works printed but not linked: 6

Serfaty L, Nousbaum JB, Elghouzzi MH, Giral P, Legendre C, Poupon followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494-1500.
Barrera JM, Bruguera M, Guadalupe-Ercilla M, Gil C, Celis R, Gil MP, del Valle Onorato M, et al. Persistent hepatitis C viremia after acute HEPATOLOGY 1995;21:725-729.
Morales TG, Sampliner RE, Bhattacharyya A, Alter MJ. Liver histology self-limiting posttransfusion hepatitis C. HEPATOLOGY 1995;21:639-644.
Alter MJ, Hadler SC, Judson FN, Mares A, Alexander J, Hu PY, Miller in anti-HCV positive persons with normal or minimally elevated amino- transferases. J Clin Gastroenterol 1995;21:301-305.
Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B, Purcell RH. A non-A, non-B hepatitis. N Engl J Med 1992;327:1906-1911.
Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Don- 1995;123:897-903.

Sorted by citations

Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Binding of Hepatitis C Virus to CD81
Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G., et al. (1998) · Science · doi:10.1126/science.282.5390.938 · Cited by 2,059
Approved Antiviral Drugs over the Past 50 Years
Clercq, E. D., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,477
The global burden of hepatitis C
Lavanchy, D. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01934.x · Cited by 1,353
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
Stanaway, J. D., Flaxman, A. D., Naghavi, M., Fitzmaurice, C., Vos, T., Abubakar, I., Abu-Raddad, L. J., Assadi, R., Bhala, N. B., Cowie, B., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30579-7 · Cited by 1,350
Course and outcome of hepatitis C
Hoofnagle, J. H. (2002) · Hepatology · doi:10.1002/hep.1840360704 · Cited by 1,083
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
Ghany, M. G., Morgan, T. R. M., & Panel, A. H. C. G. (2019) · Hepatology · doi:10.1002/hep.31060 · Cited by 991
The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral Quasispecies
Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J. C., Strazzera, A., Chien, D. Y., Muñoz, S. J., Balestrieri, A., et al. (2000) · Science · doi:10.1126/science.288.5464.339 · Cited by 882
Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C
Gerlach, J. T., Diepolder, H. M., Jung, M., Gruener, N. H., Schraut, W., Zachoval, R., Hoffmann, R. M., Schirren, C. A., Santantonio, T. A., & Pape, G. R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70353-7 · Cited by 713
Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles
André, P., Komurian-Pradel, F., Deforges, S., Perret, M., Berland, J., Sodoyer, M., Pol, S., Bréchot, C., Paranhos‐Baccalà, G., & Lotteau, V. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.6919-6928.2002 · Cited by 688
Hepatitis C Virus-Encoded Enzymatic Activities and Conserved RNA Elements in the 3′ Nontranslated Region Are Essential for Virus Replication In Vivo
Kolykhalov, A. A., Mihalik, K., Feinstone, S. M., & Rice, C. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.4.2046-2051.2000 · Cited by 606
Estimating future hepatitis C morbidity, mortality, and costs in the United States
Wong, J. B., McQuillan, G. M., McHutchison, J. G., & Poynard, T. (2000) · American Journal of Public Health · doi:10.2105/ajph.90.10.1562 · Cited by 567
CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020
Schillie, S. F., Wester, C., Osborne, M. C., Wesolowski, L. G., & Ryerson, A. B. (2020) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr6902a1 · Cited by 565
The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States
Armstrong, G. L., Alter, M. J., McQuillan, G. M., & Margolis, H. S. (2000) · Hepatology · doi:10.1002/hep.510310332 · Cited by 524
Persistence of Viremia and the Importance of Long–Term Follow–Up After Acute Hepatitis C Infection
Villano, S. A., Vlahov, D., Nelson, K. E., Cohn, S., & Thomas, D. L. (1999) · Hepatology · doi:10.1002/hep.510290311 · Cited by 478
Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring
Dufour, D. R., Lott, J. A., Nolte, F. S., Gretch, D. R., Koff, R. S., & Seeff, L. B. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.12.2050 · Cited by 445
Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours.
Danta, M., Brown, D., Bhagani, S., Pybus, O. G., Sabin, C. A., Nelson, M., Fisher, M., Johnson, A. M., & Dusheiko, G. M. (2007) · AIDS · doi:10.1097/qad.0b013e3281053a0c · Cited by 410
Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa
Edwards-Smith, C. J., Jonsson, J. R., Purdie, D. M., Bansal, A. S., Shorthouse, C., & Powell, E. E. (1999) · Hepatology · doi:10.1002/hep.510300207 · Cited by 403
Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease–helicase
Yao, N., Reichert, P., Taremi, S. S., Prosise, W. W., & Weber, P. C. (1999) · Structure · doi:10.1016/s0969-2126(00)80025-8 · Cited by 390
American Gastroenterological Association Technical Review on the Management of Hepatitis C
Dienstag, J. L., & McHutchison, J. G. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.010 · Cited by 382
The role of liver biopsy in chronic hepatitis C
Dienstag, J. L. (2002) · Hepatology · doi:10.1002/hep.1840360720 · Cited by 377
The Los Alamos hepatitis C sequence database
KUIKEN, C. L., Yusim, K., Boykin, L. M., & Richardson, R. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth485 · Cited by 379
Persistent and Transient Replication of Full-Length Hepatitis C Virus Genomes in Cell Culture
Pietschmann, T., Lohmann, V., Kaul, A., Krieger, N., Rinck, G., Rütter, G., Strand, D. J., & Bartenschlager, R. F. W. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.4008-4021.2002 · Cited by 362
Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs
Frese, M., Schwärzle, V., Barth, K., Krieger, N., Lohmann, V., Mihm, S., Haller, O., & Bartenschlager, R. F. W. (2002) · Hepatology · doi:10.1053/jhep.2002.31770 · Cited by 314
The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae
Stapleton, J. T., Foung, S. K. H., Muerhoff, A. S., Bukh, J., & Peter Simmonds, K. (2010) · Journal of General Virology · doi:10.1099/vir.0.027490-0 · Cited by 308
Racial differences in responses to therapy with interferon in chronic hepatitis C
Reddy, K. R., Hoofnagle, J. H., Tong, M. J., Lee, W. M., Pockros, P. J., Heathcote, J., Albert, D., & Joh, T. (1999) · Hepatology · doi:10.1002/hep.510300319 · Cited by 291
Subcellular Localization, Stability, and trans -Cleavage Competence of the Hepatitis C Virus NS3-NS4A Complex Expressed in Tetracycline-Regulated Cell Lines
Wölk, B., Sansonno, D. E., Kräusslich, H., Dammacco, F., Rice, C. M., Blum, H. E., & Moradpour, D. (2000) · Journal of Virology · doi:10.1128/jvi.74.5.2293-2304.2000 · Cited by 283
Global control of hepatitis C: where challenge meets opportunity
Thomas, D. L. (2013) · Nature Medicine · doi:10.1038/nm.3184 · Cited by 282
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
Rosa, D., Saletti, G., Gregorio, E. D., Zorat, F., Comar, C., D’Oro, U., Nuti, S., Houghton, M., Barnaba, V., Pozzato, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509402102 · Cited by 275
10-year follow-up after interferon-α therapy for chronic hepatitis C
Lau, D., Kleiner, D. E., Ghany, M. G., Park, Y., Schmid, P., & Hoofnagle, J. H. (1998) · Hepatology · doi:10.1002/hep.510280430 · Cited by 266
Natural history of acute and chronic hepatitis C
Maasoumy, B., & Wedemeyer, H. H. (2012) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2012.09.009 · Cited by 272
Hepatitis C: the clinical spectrum of the disease
Marcellin, P. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80368-7 · Cited by 256
Primary prevention of hepatocellular carcinoma in developing countries
Wild, C. P., & Hall, A. J. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(00)00027-2 · Cited by 226
In vivo analysis of the 3′ untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone
Yanagi, M., Claire, M. S., Emerson, S. U., Purcell, R. H., & Bukh, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2291 · Cited by 223
Characterization of Hepatitis C Virus (HCV) and HCV E2 Interactions with CD81 and the Low-Density Lipoprotein Receptor
Wünschmann, S., Medh, J. D., Klinzman, D., Schmidt, W. N., & Stapleton, J. T. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10055-10062.2000 · Cited by 222
Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation
Shepherd, J., Brodin, H., Cave, C., Waugh, N. R., Price, A., & Gabbay, J. (2004) · Health Technology Assessment · doi:10.3310/hta8390 · Cited by 211
Treatment of Hepatitis C Virus-Related Cirrhosis: A Randomized, Controlled Trial of Interferon Alfa–2B Versus No Treatment
Valla, D. C., Chevallier, M., Marcellin, P., Payen, J., TREPO, C. G., Fonck, M., Bourlière, M., Boucher, E., Miguet, J., Parlier, D., et al. (1999) · Hepatology · doi:10.1002/hep.510290616 · Cited by 211
Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway
Frese, M., Pietschmann, T., Moradpour, D., Haller, O., & Bartenschlager, R. F. W. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-4-723 · Cited by 211
Transcripts of a Chimeric cDNA Clone of Hepatitis C Virus Genotype 1b Are Infectiousin Vivo
Yanagi, M., Claire, M. S., Shapiro, M., Emerson, S. U., Purcell, R. H., & Bukh, J. (1998) · Virology · doi:10.1006/viro.1998.9092 · Cited by 209
Public health bulletin
Kohl, M. (1997) · Nursing · doi:10.1097/00152193-199712000-00004 · Cited by 204
Acute hepatitis C.
Orland, J. R., Wright, T. L., & Cooper, S. (2001) · Hepatology · doi:10.1053/jhep.2001.22112 · Cited by 196
Hepatitis C therapeutics: current status and emerging strategies
Tan, S., Pause, A., Shi, Y., & Sonenberg, N. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd937 · Cited by 197
The epidemiology of hepatitis C infection in the United States
Rustgi, V. K. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2064-6 · Cited by 188
Chronic Hepatitis C Virus Infection in Childhood: Clinical Patterns and Evolution in 224 White Children
Jara, P., Resti, M., Hierro, L., Giacchino, R., Barbera, C., Zancan, L., Crivellaro, C. E., Sokal, E. M., Azzari, C., Guido, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/345908 · Cited by 187
Hepatitis C Virus: An Infectious Molecular Clone of a Second Major Genotype (2a) and Lack of Viability of Intertypic 1a and 2a Chimeras
Yanagi, M., Purcell, R. H., Emerson, S. U., & Bukh, J. (1999) · Virology · doi:10.1006/viro.1999.9889 · Cited by 176
Perspectives for the Treatment of Infections with Flaviviridae
Leyssen, P., Clercq, E. D., & Neyts, J. H. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.67-82.2000 · Cited by 176
Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis C: a rapid and systematic review.
Shepherd, Waugh, & Hewitson (2000) · Health Technology Assessment · doi:10.3310/hta4330 · Cited by 175
The effects of HCV infection and management on health-related quality of life
Younossi, Z. M., Kallman, J. B., & Kincaid, J. (2007) · Hepatology · doi:10.1002/hep.21565 · Cited by 173
Alternative Approaches for Efficient Inhibition of Hepatitis C Virus RNA Replication by Small Interfering RNAs
Krönke, J., Kittler, R., Buchholz, F., Windisch, M. P., Pietschmann, T., Bartenschlager, R. F. W., & Frese, M. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3436-3446.2004 · Cited by 172
Interferon-Induced Depression in Chronic Hepatitis C: A Review of Its Prevalence, Risk Factors, Biology, and Treatment Approaches
Asnis, G. M., & Garza, R. D. L. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000210099.36500.fe · Cited by 170
Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors
Golden, J., O'Dwyer, A. M., & Conroy, R. M. (2005) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2005.06.006 · Cited by 211
Hepatitis C in Egypt – past, present, and future
Elgharably, A., Gomaa, A. I., Crossey, M. M. E., Norsworthy, P. J., Waked, I. A., & Taylor-Robinson, S. D. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s119301 · Cited by 162
Identification and In Vitro Expansion of Functional Antigen-Specific CD25 + FoxP3 + Regulatory T Cells in Hepatitis C Virus Infection
Ebinuma, H., Nakamoto, N., Li, Y., Price, D. A., Emma Gostick, D., Levine, B. L., Tobias, J. W., Kwok, W. W., & Chang, K. (2008) · Journal of Virology · doi:10.1128/jvi.01548-07 · Cited by 160
Activated T lymphocytes bindin situ to stromal tissue of colon carcinoma but lack adhesion to tumor cells
Krüger, K., Büning, C., & Schriever, F. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200101)31:1 · Cited by 27
Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C: A Cost-Effectiveness Analysis
Wong, J. B., & Koff, R. S. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-9-200011070-00008 · Cited by 156
Detection of novel biomarkers of liver cirrhosis by proteomic analysis #
Mölleken, C., Sitek, B., Henkel, C., Poschmann, G., Sipos, B., Wiese, S., Warscheid, B., Broelsch, C. E., Reiser, M., Friedman, S. L., et al. (2008) · Hepatology · doi:10.1002/hep.22764 · Cited by 149
All-Cause, Liver-Related, and Non-Liver-Related Mortality Among HCV-Infected Individuals in the General US Population
El‐Kamary, S. S., Jhaveri, R. R., & Shardell, M. D. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir306 · Cited by 147
Persistence Rate and Progression of Vertically Acquired Hepatitis C Infection
European Paediatric Hepatitis C Virus Infection Network, Tovo, P., Pembrey, L., & Newell, M. (2000) · The Journal of Infectious Diseases · doi:10.1086/315264 · Cited by 141
An infectious molecular clone of a Japanese genotype 1b hepatitis C virus
Beard, M. R., Abell, G., Honda, M., Carroll, A. R., Gartland, M. J., Clarke, B. E., Suzuki, K., Lanford, R. E., Sangar, D. V., & Lemon, S. M. (1999) · Hepatology · doi:10.1002/hep.510300137 · Cited by 142
Direct Economic Burden of Chronic Hepatitis C Virus in a United States Managed Care Population
Davis, K. L., Mitra, D., Medjedovic, J., Beam, C., & Rustgi, V. K. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181e12c09 · Cited by 140
Quasispecies in viral persistence and pathogenesis of hepatitis C virus
Forns, X., Purcell, R. H., & Bukh, J. (1999) · Trends in Microbiology · doi:10.1016/s0966-842x(99)01590-5 · Cited by 139
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis
Bonkovsky, H. L., Snow, K. K., Malet, P. F., Back‐Madruga, C., Fontana, R. J., Sterling, R. K., Kulig, C. C., Bisceglie, A. M. D., Morgan, T. R. M., Dienstag, J. L., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.009 · Cited by 137
Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics
Usman, N., & Blatt, L. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11631 · Cited by 137
Transplantation in the Patient with Hepatitis C
Morales, J. M., & Campistol, J. M. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1171343 · Cited by 134
Fatigue and Health-Related Quality of Life (HRQL) in Chronic Hepatitis C Virus Infection
Kallman, J., O’Neil, M. M., Larive, B., Boparai, N., Calabrese, L., & Younossi, Z. M. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9708-x · Cited by 181
Clinical course of infection and viral tissue tropism of hepatitis C virus–like nonprimate hepaciviruses in horses
Pfaender, S., Cavalleri, J. V., Wälter, S., Doerrbecker, J., Campana, B., Brown, R. J. P., Burbelo, P. D., Postel, A., Hahn, K., Anggakusuma, et al. (2014) · Hepatology · doi:10.1002/hep.27440 · Cited by 133
Chronic Hepatitis C Virus Infection
Flamm, S. L. (2003) · JAMA · doi:10.1001/jama.289.18.2413 · Cited by 133
Role of the Asialoglycoprotein Receptor in Binding and Entry of Hepatitis C Virus Structural Proteins in Cultured Human Hepatocytes
Saunier, B., Triyatni, M., Ulianich, L., Maruvada, P., Yen, P. M., & Kohn, L. D. (2002) · Journal of Virology · doi:10.1128/jvi.77.1.546-559.2003 · Cited by 133
SAR and Mode of Action of Novel Non-Nucleoside Inhibitors of Hepatitis C NS5b RNA Polymerase
Powers, J. P., Piper, D. E., Li, Y., Mayorga, V., Anzola, J. V., Chen, J., Jaén, J. C., Lee, G., Liu, J., Peterson, M. G., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050859x · Cited by 131
Emotional distress in chronic hepatitis C patients not receiving antiviral therapy
Fontana, R. J., Hussain, K. B., Schwartz, S. M., Moyer, C. A., Su, G. L., & Lok, A. S.-F. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00280-x · Cited by 131
Aflatoxin, Hepatitis and Worldwide Liver Cancer Risks
Henry, S. H., Bosch, F. X., & Bowers, J. C. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0629-4_24 · Cited by 129
Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes
Dionisio, N., García‐Mediavilla, M. V., Sánchez‐Campos, S., Majano, P. L., Benedicto, I., Rosado, J. A., Salido, G. M., & González‐Gallego, J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.026 · Cited by 131
Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis
Mehta, A. S., Long, R. E., Comunale, M. A., Wang, M., Rodemich-Betesh, L., Krakover, J. D., Philip, R., Marrero, J. A., Dwek, R. A., & Block, T. M. (2007) · Journal of Virology · doi:10.1128/jvi.01600-07 · Cited by 125
Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection
Farinati, F., Cardin, R., Degan, P., Maria, N. D., Floyd, R. A., Thiel, D. H. V., & Naccarato, R. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00161-6 · Cited by 123
Template Requirements for RNA Synthesis by a Recombinant Hepatitis C Virus RNA-Dependent RNA Polymerase
Kao, C. C., Yang, X., Kline, A. D., Wang, Q. M., Barket, D., & Heinz, B. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11121-11128.2000 · Cited by 123
Hepatitis C
Sarbah, S. A., & Younossi, Z. M. (2000) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200003000-00005 · Cited by 122
Fatigue, depression and chronic hepatitis C infection
Wessely, S. C., & Pariante, C. M. (2002) · Psychological Medicine · doi:10.1017/s0033291701004615 · Cited by 121
Myocarditis and Heart Failure Associated With Hepatitis C Virus Infection
Matsumori, A., Shimada, T., Chapman, N. M., Tracy, S., & Mason, J. W. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.11.004 · Cited by 121
Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
Burroughs, A. K., Groszmann, R., Bosch, J., Grace, N., Garcia-Tsao, G., Patch, D., García‐Pagán, J. C., & Dagher, L. (2002) · Gut · doi:10.1136/gut.50.3.425 · Cited by 121
Cerebral dysfunction in chronic hepatitis C infection
Forton, D. M., Taylor-Robinson, S. D., & Thomas, H. C. (2003) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00416.x · Cited by 118
Therapy of Viral Hepatitis
Hoofnagle, J. H. (1998) · Digestion · doi:10.1159/000007532 · Cited by 116
The impact of hepatitis C virus infection on work absence, productivity, and healthcare benefit costs†
Su, J., Brook, R. A., Kleinman, N. L., & Corey‐Lisle, P. K. (2010) · Hepatology · doi:10.1002/hep.23726 · Cited by 116
Detection of hepatitis C virus replication by In situ hybridization in epithelial cells of anti-hepatitis C virus-positive patients with and without oral lichen planus
Arrieta, J. J., Rodríguez‐Iñigo, E., Casqueiro, M., Bartolomé, J., Manzarbeitia, F., Herrero, M., Pardo, M., & Carréño, V. (2000) · Hepatology · doi:10.1053/jhep.2000.8533 · Cited by 115
Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes
Macejak, D. G., Jensen, K. L., Jamison, S. F., Domenico, K., Roberts, E. C., Chaudhary, N., von Carlowitz, I., Bellon, L., Tong, M. J., Conrad, A. J., et al. (2000) · Hepatology · doi:10.1002/hep.510310331 · Cited by 114
Chronic viral hepatitis as a public health issue in the world
Lavanchy, D. (2008) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2008.11.002 · Cited by 113
Hepatitis C Virus NS5A Protein Impairs TNF-Mediated Hepatic Apoptosis, but Not by an Anti-FAS Antibody, in Transgenic Mice
Majumder, M., Ghosh, A. K., Steele, R., Zhou, X., Phillips, N. J., Ray, R., & Ray, R. B. (2002) · Virology · doi:10.1006/viro.2001.1309 · Cited by 114
Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice
Ciurea, A., Klenerman, P., Hunziker, L., Horváth, E. J., Odermatt, B., Ochsenbein, A. F., Hengartner, H., & Zinkernagel, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11964 · Cited by 109
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015
Monaco, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i42.11974 · Cited by 109
Experimental transmission of equine hepacivirus in horses as a model for hepatitis C virus
Ramsay, J. D., Evanoff, R. M., Wilkinson, T., Divers, T. J., Knowles, D. P., & Mealey, R. H. (2015) · Hepatology · doi:10.1002/hep.27689 · Cited by 107
Identification of a Novel Hepacivirus in Domestic Cattle from Germany
Baechlein, C., Fischer, N., Grundhoff, A. T., Alawi, M., Indenbirken, D., Postel, A., Baron, A. L., Offinger, J., Becker, K., Beineke, A., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00534-15 · Cited by 107
Hepatitis C Virus–Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1
Yergin, C. G., Roggerson, K. M., Lee, H., Golden‐Mason, L., Rosen, H. R., & Hahn, Y. S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501881 · Cited by 107
Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing
Ward, C., Tudor‐Williams, G., Cotzias, T., Hargreaves, S., Regan, L., & Foster, G. R. (2000) · Gut · doi:10.1136/gut.47.2.277 · Cited by 107
Inactivation and Survival of Hepatitis C Virus on Inanimate Surfaces
Doerrbecker, J., Friesland, M., Ciesek, S., Erichsen, T. J., Mateu‐Gelabert, P., Steinmann, J., Steinmann, J., Pietschmann, T., & Steinmann, E. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir535 · Cited by 106
Clinical consequences of hepatitis C virus infection
Zoulim, F., Chevallier, M., Maynard, M., & TREPO, C. G. (2002) · Reviews in Medical Virology · doi:10.1002/rmv.371 · Cited by 106
A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection
Forton, D. M., Allsop, J. M., Cox, I. J., Hamilton, G., Wesnes, K. A., Thomas, H. C., & Taylor-Robinson, S. D. (2005) · AIDS · doi:10.1097/01.aids.0000192071.72948.77 · Cited by 106
Outcome of Hospital Care of Liver Disease Associated With Hepatitis C in the United States
Kim, W. R., Gross, J. B., Poterucha, J. J., Locke, R. G., & Dickson, R. E. (2001) · Hepatology · doi:10.1053/jhep.2001.20798 · Cited by 106
Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin
Gopal, D. V., Rabkin, J. M., Berk, B. S., Corless, C. L., Chou, S., Olyaei, A. J., Orloff, S. L., & Rosen, H. R. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.22447 · Cited by 106
Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients
Tomás, J., Pinilla, I., Garcia-Buey, M., García, A. A., Figuera, A., de Soria, V. G.-G., Moreno, R., & Fernández-Rañada, J. M. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702532 · Cited by 105
The Chimpanzee Model of Hepatitis C Virus Infections
Lanford, R. E., Bigger, C. B., Bassett, S. E., & Klimpel, G. R. (2001) · ILAR Journal · doi:10.1093/ilar.42.2.117 · Cited by 104
Health-Related Quality of Life and Depression in Patients with Chronic Hepatitis C
Gallegos-Orozco, J. F., Fuentes, A. P., Argueta, J. G., Pérez-Pruna, C., Hinojosa, C. A., Sixtos-Alonso, M. S., Cruz-Castellanos, S., Gutiérrez‐Reyes, G., Olivera-Martinez, M. A., Gutiérrez‐Ruíz, M. C., et al. (2003) · Archives of Medical Research · doi:10.1016/s0188-4409(03)00003-1 · Cited by 102

Authors: Hoofnagle, J. H.
Affiliations: National Institutes of Health (US)
Corresponding author: Hoofnagle, J H
Venue: Hepatology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1997-12
Volume: 26
Issue: Supplement 3
Pages: 15S-20S
ISSN: 0270-9139 (ISSN-L)
DOI: 10.1002/hep.510260703
OpenAlex: W1979931682
Cited by: 765
References: 47
Citations by year: 2026: 3 · 2025: 8 · 2024: 11 · 2023: 8 · 2022: 8 · 2021: 14 · 2020: 9 · 2019: 10 · 2018: 14 · 2017: 11 · 2016: 25 · 2015: 20 · 2014: 32 · 2013: 26 · 2012: 20
FWCI: 27.00
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 6483 d)
Locations: Hepatology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Hepatitis C virus research
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords: hepatitis C, hepatitis C virus, acute hepatitis C, chronic hepatitis C, end-stage liver disease, liver cirrhosis, hepatocellular carcinoma, extrahepatic manifestations, cryoglobulinemia, glomerulonephritis, aminotransferase elevation, HCV RNA, incubation period, clinical spectrum
MeSH terms: Acute Disease, Transaminases, Chronic Disease, Hepatitis C, Humans, Severity of Illness Index, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hepatitis C: the clinical spectrum of disease.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks